"Company","Parent Company","Penalty Amount","Subtraction From Penalty","Penalty Amount Adjusted For Eliminating Multiple Counting","Penalty Year","Penalty Date","Offense Group","Primary Offense","Secondary Offense","Description","Level of Government","Action Type","Agency","Civil/Criminal","Prosecution Agreement","Court","Case ID","Private Litigation Case Title","Lawsuit Resolution","Facility State","City","Address","Zip","NAICS Code","NAICS Translation","HQ Country of Parent","HQ State of Parent","Ownership Structure","Parent Company Stock Ticker","Major Industry of Parent","Specific Industry of Parent","Info Source","Notes"
"IMMUNOMEDICS, INC. EMPLOYEES' 401(K) SAVINGS PLAN","Gilead Sciences","$10,001","$0","$10,001","2001","20010518","employment-related offenses","benefit plan administrator violation","","Deficient Filer","federal","agency action","Employee Benefits Security Administration","civil","","","","","","","","","","","","USA","California","publicly traded","GILD","pharmaceuticals","pharmaceuticals","Included in a dataset downloaded at https://enforcedata.dol.gov/views/data_summary.php","Company is plan administrator. Penalty amount reported in range of $10,001 to $50,000. "
"GILEAD SCIENCES","Gilead Sciences","$5,700","$0","$5,700","2000","20000128","safety-related offenses","workplace safety or health violation","","","federal","agency action","Occupational Safety & Health Administration","civil","","","","","","California","FOSTER CITY","333 LAKESIDE DRIVE","94404","000000","","USA","California","publicly traded","GILD","pharmaceuticals","pharmaceuticals","Extracted from a download of OSHA's Enforcment Data downloaded on 3/02/2022, available at https://enforcedata.dol.gov/views/data_catalogs.php",""
"Gilead Sciences","Gilead Sciences","$250,000","$0","$250,000","2013","20131118","government-contracting-related offenses","False Claims Act and related","","The Louisiana Attorney General's Office announced that it had obtained a total of $88 million in settlements from 25 pharmaceutical companies to resolve allegations they overcharged the state's Medicaid program.","state","agency action","Louisiana Attorney General","civil","","","","","","Louisiana","","","","","","USA","California","publicly traded","GILD","pharmaceuticals","pharmaceuticals","https://web.archive.org/web/20140227115735/http://www.ag.state.la.us/Article.aspx?articleID=788&catID=2",""
"Gilead Sciences, Inc.","Gilead Sciences","$97,000,000","$0","$97,000,000","2020","20200923","government-contracting-related offenses","False Claims Act and related","kickbacks and bribery","Gilead Sciences, Inc. agreed to pay $97 million to resolve claims that it violated the False Claims Act by illegally using a foundation as a conduit to pay the copays of thousands of Medicare patients taking Gilead's pulmonary arterial hypertension drug, Letairis.","federal","agency action","Justice Department Civil Division","civil","","","","","","","","","","","","USA","California","publicly traded","GILD","pharmaceuticals","pharmaceuticals","https://www.justice.gov/opa/pr/gilead-agrees-pay-97-million-resolve-alleged-false-claims-act-liability-paying-kickbacks",""
